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Summary The biodistribution of two recently developed tumour markers, trimethylated (CP(Me)3) and trimethoxylated (CP(OMe)3)
carotenoporphyrin, was investigated by means of laser-induced fluorescence (LIF) after i.v. injection into 38 tumour-bearing (MS-2
fibrosarcoma) female Balb/c mice. At 3, 24, 48 or 96 h after administration, the carotenoporphyrin fluorescence was measured in tumoral and
peritumoral tissue, as well as in the abdominal, thoracic and cranial cavities. The fluorescence was induced by a nitrogen laser-pumped dye
laser, emitting light at 425 nm, and analysed by a polychromator equipped with an image-intensified CCD camera. The fluorescence was
evaluated at 490, 655 and 720 nm: the second and third wavelengths represent the carotenoporphyrin (CP)-related peaks, whereas the first
one is close to the peak of the tissue autofluorescence. The tumour and the liver were the two tissue types showing the strongest
carotenoporphyrin-related fluorescence, whereas the cerebral cortex and muscle consistently exhibited weak substance-related
fluorescence. In most tissue types, the fluorescence intensities decreased over time. A few exceptions were observed, notably the liver, in
which the intensity remained remarkably constant over the time period investigated.
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One of the most important factors for successful treatment of
malignant tumours is early detection. Therefore, the development
of new techniques for more sensitive and less invasive tumour
diagnosis is desirable. Laser-induced fluorescence (LIF) is a
promising and rapidly developing technique by which the fluores-
cence from endogenous as well as exogenously administered fluo-
rophores is investigated (Profio, 1990; Andersson-Engels et al,
1992). It has been shown that the fluorescence emission is altered
very early in the tissue transformation into malignancy (Lam et al,
1990; Baert et al, 1992). The laser is ideal as an excitation source,
as the light emitted is monochromatic and can be coupled effi-
ciently into an optical fibre. Optical fibres can easily be inserted
into a regular white-light endoscope for investigations of the
tracheobronchial area, the urinary bladder or the gastrointestinal
system. In addition to using a single optical fibre for point
measurements, larger areas can be imaged by means of CCD
cameras and imaging fibre bundles. Using a split-mirror telescope,
the fluorescence can be imaged at several wavelengths simultane-
ously. With computer processing, real-time images with an
enhanced tumour contrast can be obtained (Andersson-Engels et
al, 1994). This appears to be an attractive modality for early
tumour detection in endoscopically reachable organs, in which
larger areas can be investigated at once, yielding colour-coded
images ofa tumour region.
LIF diagnostics has been based primarily on the fact that
porphyrins, and certain derivatives thereof, are accumulated in
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malignant neoplastic tissue and thatthey emit a characteristic fluo-
rescence profile when excited with light in the ultraviolet (UV) or
near-UV wavelength region, usually with a dual-peaked emission
in the red wavelength region above 600 nm. Apart from the
substance-related fluorescence, an autofluorescence signal in the
blue-green region, peaking at about 500 nm, is also seen. The
endogenous fluorescence is emitted from the excitation ofconnec-
tive tissue matrix proteins, such as collagen and elastin, and also
from co-factors in the cell respiration, namely the redox pair
NADH/NAD+, as well as various flavins. It has been reported
repeatedly that the intensity of the autofluorescence is low in
malignant tumours compared with non-transformed surrounding
tissues (see, for example, Ankerst et al, 1984; Svanberg et al,
1986). This is sometimes attributed to a change in the equilibrium
between NADH and NADH+ due to the decreased pH in most
tumours (Andersson-Engels etal, 1990). The reduced fluorescence
intensity can very favourably be included in the diagnostic crite-
rion, thus enhancing the demarcation between malignantneoplasia
and healthy tissue.
Haematoporphyrin derivatives (HpDs) and other substances
with a tetrapyrrole ring structure have primarily been developed
for use in photodynamic therapy (PDT). It is well known that HpD
and other sensitizers are accumulated to a certain degree in the
skin and, therefore, the patients have to avoid ambient daylight for
some time afteradministration. Thus, forfluorescence diagnostics,
the photodynamic action is an undesired effect. This dilemma has
partly been solved by using the drugs at lower doses (Lam et al,
1990; Baert et al, 1992). However, this dose reduction usually
decreases detection sensitivity.
Recently, an entirely new class of substances based on a
porphyrin ring with a covalently attached carotenoid polyene has
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Figure 1 Chemical structures of the carotenoporphyrins used in the present investigation. Two corresponding porphyrins are included for comparison. P, porphyrin; CP, carotenoporphyrin; Me, methyl; OMe, methoxy
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Figure 2 Laser-induced fluorescence spectra of (A) liver, (B) small intestine and (C) heart, all 3 h after i.v. administration of 4.2 ,umol kg-1 CP(Me)3 and (D)
trachea 48 h after i.v. injection of 4.2 gmol kg-' CP(Me)3. A denotes the background-free main carotenoporphyrin peak at 654 nm. B represents the
autofluorescence evaluated at 490 nm
been developed (Figure 1). These carotenoporphyrins (CPs) have
several unique properties. First ofall, the excited porphyrin triplet
state, which is the most reactive intermediate in the porphyrin-
photosensitized processes, is efficiently quenched by the carotene
moiety. Thus, no singlet oxygen (102) is produced (Moore et al,
1982; Gust et al, 1992a). Hence, the CP is mimicking carotenoid
photoprotection such as found in the green plant photosynthetic
reaction centres. Further, if '02 from any source is present, the 102
is deactivated by the carotenoid moiety via the energy transfer
process: 102+ carotenoid -+ 3° + 3carotenoid (Cogdell and Frank,
1987). These favourable properties of CPs suggest that they
could be potential candidates for clinical in vivo LIF diagnostics
(Reddi et al, 1994).
MATERIALS AND METHODS
Chemicals
One trimethylated (CP(Me)3) and one trimethoxylated (CP(OMe)3)
carotenoporphyrin was used in the experiments. These substances
were synthesized according to aprocedure previously described by
Gust et al (1992b). Both substances were solubilized in a
Cremophor EL emulsion and were i.v. injected at a dose of
4.2 gmol kg-' body weight, corresponding to 5.0 mg kg-' CP(Me)3
and 5.2 mg kg-' CP(OMe)3 (Reddi et al, 1994).
Animals and tumours
Female Balb/c mice weighing 18-22 g were inoculated with
0.2 ml of a cell suspension containing 106 MS-2 fibrosarcoma
cells ml-' in the right hind leg 6 days before the first day of
measurements. The measurements were carried out over a period
of4 days. As the experimental tumours grew quickly, outstripping
their vascular supplies, the animals investigated on the third and
fourth day had partly necrotic tumours. The consequences of this
will be discussed.
Fluorescence measurements
Forty-three female Balb/c mice were investigated. Five control
animals were not injected, of which three were analysed on the
first day of the experiment and two on the last day. Nineteen
animals were injected with CP(Me)3 and 19 with CP(OMe)3. The
injected mice were analysed 3, 24, 48 or 96 h after injection. At 3
and 24h, five mice injected with CP(Me)3 and five with CP(OMe)3
were investigated. At 48 h, four animals in each group were
analysed, and at 96 h three animals in each group were investi-
gated completely, while two were analysed only with respect to the
tumour and peritumoral muscle.
The tumour fluorescence was investigated according to the
procedure described previously by Nilsson et al (1994). An optical
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Figure 3 Data evaluated for different organs at 3 (top left), 24 (top right), 48 (bottom left) or 96 h (bottom right) after i.v. injection with 4.2gimol kg-' of CP(Me)3.
The data represent an average of the background-free fluorescence intensities at 654 nm (A) for the various organs, expressed in units relative to the average
value of tumour exterior, which is set to 1. The bars indicate ± one standard deviation. The figures in bold face above the dashed lines are explained in the text
fibre-based multichannel analyser that records in situ fluorescence
spectra was used. The fluorescence probe consists of a single
600gim optical fibre, the size of which determines the tissue area
under investigation. After sacrifice of the animals, the abdomen
and the thoracic cage were cut open. In addition, the trachea was
carefully dissected to enable insertion of the optical fibre and
intraluminally measurement in the organ. The abdominal organs
and the rest of the thoracic viscera were analysed in situ, with the
optical fibre placed on the outer surfaces ofthe organs, thus mini-
mizing the risk of haemorrhage, and simultaneously, trying to
mimic the in vivo situation to as great an extent as possible. In the
abdomen, the organs responsible for excretion of the substances,
the liver and the intestines (i.e. excretion via the hepatobiliary
route) (Reddi et al, 1994), were analysed, as well as the kidneys
and the urinary bladder. In some animals, the bladder was full of
urine, whereas in others it was half-full or completely empty, as a
result ofeither urination or manual emptying by the investigators.
The fluorescence of the stomach was also measured, but none
of the values obtained was processed because of a very strong
fluorescence peak at about 670 nm and another one above
700 nm, interfering with the carotenoporphyrin fluorescence
peaks at 655 and 720 nm. Furthermore, in most spectra captured
from the large and small intestine, on the surface of the skin,
and on the abdominal muscle wall, a fluorescence peak at
about 670 nm caused strong interference with the carotenopor-
phyrin fluorescence peaks. The fluorescence from the spleen,
lungs, heart and the trachea was also measured. Finally, the
calvarium was removed and the underlying cerebral cortex was
probed.
In the presence of blood, the fluorescence signal was severely
distorted as a result of the strong reabsorption by haemoglobin at
540 and 580 am. The interaction ofhaemoglobin was particularly
prominent when monitoring the lungs, spleen and trachea. This
was also evident in the necrotic tumours, where haemorrhages
occurred when measurements were made ofthe interiorpart ofthe
tumours (Nilsson et al, 1994). Sometimes this interference was
evident on probing the exterior capsule of the tumour, because of
subcapsular haemorrhages, again due to tumour necrosis.
Equipment
A detailed description of the experimental set-up has been
given (Andersson-Engels et al, 1989; Andersson-Engels et at,
1991). The excitation source was a nitrogen laser (Laser Science
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Figure 4 Data evaluated for different organs at 3 (top left), 24 (top right), 48 (bottom left) or 96 h (bottom right) after i.v. injection with 4.2 gimol kg-' of
CP(OMe)3. The data represent an average of the background-free fluorescence intensities at 658 nm (A) for the various organs, expressed in units relative to
the average value of tumour exterior, which is set to 1. The bars indicate ± one standard deviation. The figures in bold face above the dashed lines are
explained in the text
VSL-337ND) with a pulse duration of 3 ns, a repetition rate of
10 Hz and an output pulse energy of 180pJ. The laser emission at
337 nm was used as a pump source for a compact tunable dye laser
(Laser Science DLM220). By turning a grating, the dye laser was
set to emit light at 425 nm, which is close to the absorption peak of
the CPs. The output pulse energy was about 20 pJ. The light was
guided through a 600-pm quartz optical fibre, the distal end of
which was held in close contact with the tissue sample being
analysed. The resulting fluorescence was collected by the same
fibre and guided back to the 100-,im entrance slit of a polychro-
mator (Acton SP-275) via a dichroic mirror, which blocked the
reflected excitation light, and a 455-nm cut-off filter to eliminate
any residual elastically back-scattered excitation light. An image-
intensified CCD camera (Spectroscopy Instr. ICCD-576G/R)
placed at the focus of the polychromator, served as the detector.
This 576 x 384 pixel CCD camera was cooled to -20°C to reduce
the dark current. For each spectrum captured, the fluorescence
light from 50 laser pulses was integrated, although useful signal-
noise ratios in most cases were obtained in single-shot mode. More
than 2500 integrated spectra were recorded and stored in a
computer for later processing and evaluation.
RESULTS
Figure 2A shows a typical fluorescence spectrum from liver
tissue recorded 3 h after administration of CP(Me)3 with the
dual-peaked substance-related fluorescence at about 655 and
720 nm. The background-free substance-related peak of
CP(Me)3, located at about 654 nm, is denoted A in the figure.
The autofluorescence, denoted B, was evaluated at 490 nm. For
CP(OMe)3, the main peak is located at 658 nm and the second
peak at about 722 nm. The background-free main peak is also in
this case denoted A. The differences between the recorded
spectra were seen in the intensity at the peak wavelengths for CP
as well as the endogenous fluorescence profiles for the different
organs. In some organs, additional fluorescence peaks were
detected. In the gastrointestinal system, the skin and the abdom-
inal wall, a prominent peak at 672 nm and interference above
700 nm were observed (Figure 2B). This feature will be
discussed below. Also, in the spectra recorded from the heart and
some of the tumours, a peak at approximately 596 nm was seen
(Figure 2C). Finally, in a few cases, a peak at around 630 nm was
detected (Figure 2D).
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Figure 7 Data evaluated for different organs at 3 (top left), 24 (top right), 48 (bottom left) or 96 h (bottom right) after i.v. injection with 4.2 gmol kg-' of CP(Me)3.
The data represent an average of the background-free fluorescence intensities at 654 nm (A) divided by the autofluorescence, evaluated at 490 nm (B) for the
various organs (i.e. ANB), expressed in units relative to the average value for tumour exterior, which is set to 1. The bars indicate ± one standard deviation
Figure 3 presents the data obtained during the measurements on
CP(Me)3, at 3, 24, 48 and 96 h after i.v. injection. The y-axes
display the fluorescence intensities at 654 nm (A) for the various
tissues, expressed in units relative to tumourexterior(i.e. measure-
ments on the tumours after removal ofthe overlying skin; Nilsson
et al, 1994). The value of tumour exterior is set to unity. The
figures printed in bold face above the dashed lines represent multi-
plication factors, relating the measurements at the different time
points to each other. In some ofthe graphs, a few values have been
deleted as a result ofinterference by non-substance-related peaks.
This phenomenon is especially prominent for the non-substance-
related peak at 672 nm, which interferes with the A peak. No
single point is based on fewer than two recordings. The vertical
bars indicate ± one standard deviation. In some cases, there were
no values at all at a specific location for a specific subgroup of
mice. Forexample, at 3 h, all the mice ofthis subgroup hadurinary
bladders that were full of urine, and no mouse had an empty
bladder. However, for the sake of consistency, all x-axes are
labelled similarly. This same reasoning holds true for Figure 4,
with the only difference being that this figure depicts the data
collected from the mice injected with CP(OMe)3.
It has previously been shown that the recorded CP fluorescence
from tumour exterior increases over the first 48 h, and then drops
during the consecutive 48 h, to reach alow level at96 h afterinjec-
tion (Nilsson et al, 1994; Reddi et al, 1994). It can be concluded
from Figure 3 that no organ except the liver exhibits a stronger
CP(Me)3 fluorescence at 654 nm than does the tumour exterior.
For the liver, the substance-related fluorescence intensity at
654 nm remains almost constant over time (Figure 5). The spleen,
on the other hand, follows the pattern of the tumour exterior,
increasing up to 48 h and then falling offduring the next 48 h. The
kidney has a decreasing profile over the whole period. An organ
that only exhibited a minute fluorescence intensity at 654 nm, in
all fourbatches, was the cerebral cortex. Another interesting point
is that the empty bladder exhibits a more intense (A) fluorescence
than the full bladder. On the otherhand, the full bladders exhibited
a very strong autofluorescence, peaking between 520 and 530 nm,
which is not seen in the empty bladders. The trachea and the lung
displayed a decreasing pattern, similar to the kidney.
Figures 4 and 6 show the corresponding data for CP(OMe)3. The
interference from non-substance-related peaks, described for
Figure 3, is not as prominent in Figure 4, probably because of
a higher accumulation of the trimethoxylated carotenoporphyrin
or because of a higher fluorescence yield, which allows the
substance-related fluorescence to dominate over other fluorescence
signatures. In the case of CP(OMe)3, tumour exterior exhibits its
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strongest 658 nm fluorescence 3 h after administration of the
substance and then the intensity slowly decreases overtime (Nilsson
et al, 1994). As in the case of CP(Me)3, the liver is the only organ
with a substance-related fluorescence similar to that oftumour exte-
rior. The liver fluorescence is approximately equal between 3 and
24 h and then falls off to approximately one half the original peak
intensity at the 48 and 96 h measurements (Figure 6). The fluores-
cence intensity obtained on probing the spleen increases at 658 nm
between 3 and 24 h, and decreases after that. The renal fluorescence
follows the same trend as in Figure 3, i.e. the peak intensity has its
maximum at 3 h and then decreases over time. The small intestine,
lung and trachea yield high initial fluorescence intensities at
658 nm, which are quickly reduced, as demonstrated by measure-
ments after the 3-h batch. Finally, only a very low fluorescence
intensity is obtained at all times when probing the cerebral cortex.
In Figures 7 and 8, the ratio of the carotenoporphyrin-related
fluorescence to the autofluorescence is presented for the different
organs and for the two different substances. The ratio is higher for
tumour than for any other ofthe studied organs. This is because of
a decrease of the autofluorescence intensity in the tumour, as has
been shown previously (Ankerst et al, 1984; Hung et al, 1991).
DISCUSSION
The two CPs used in this study are good tumour localizers with
fluorescence signatures that are easily detectable. In general, the
overall pattern of the biodistribution data presented herein is in
very good agreement with that obtained by chemical extraction
studies (Reddi et al, 1994) although a few discrepancies between
the in vivo/ex vivo and in vitro analytical methods can be distin-
guished. Reddi et al (1994) showed that the spleen accumulates
large amounts of both substances. In our study, however, it is not
evident that this is the case. The reason for this is probably that
organs rich in blood, such as the spleen, the lungs and to some
extent the kidneys, exhibit a severely reduced fluorescence signal,
principally because of absorption of the excitation light and reab-
sorption ofthe fluorescence by haemoglobin (Hb). Since the Soret
absorption band for HbO2 is located at 420 nm and the excitation
wavelength used was 425 nm, the absorption is very prominent.
Further, the two absorption Q-bands at 540 and 580 nm for HbO2
did interfere with the autofluorescence signal in the green-yellow
spectral region in some cases, creating 'reabsorption dips' in the
corresponding fluorescence spectra.
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The behaviour of the CPs is quite typical of porphyrin deriva-
tives administered by way of hydrophobic delivery systems and
eliminated via the hepatobiliary route, as indicated by the large
amounts ofthe substances accumulated in the liverandspleen (Jori,
1987). Furtherindications ofthis can be found inFigure4, in which
the small intestine exhibits ahigh fluorescence at the wavelength of
the main peak A at 3 h and, to somedegree, at 24 h. Figures 3 and 4
also show that only very small amounts of CPs seem to cross the
blood-brain barrier and reach the cerebral cortex, as illustrated by
the low substance-related fluorescence intensities at all times for
this organ. The pattern ofCP(OMe)3-related fluorescence retrieved
from the lung and trachea, with a high initial intensity soon
followed by amarkedreduction, couldbebecause oftrapping in the
microvasculature of these organs (Alian et al, 1994). This process
could either be an active accumulation in the reticuloendothelial
cells or apassive trapping. Theoretically, the CPs could traverse the
plasma membranes ofthe endothelial cells because ofthe relatively
hydrophobic nature ofthese compounds.
Figures 7 and 8 clearly point outthe benefits ofusing the ratio of
the background-free substance-related fluorescence and the auto-
fluorescence for tumour demarcation purposes. Tumour exterior
exhibits a ratio that is at least a factor of2 greater than it is for any
other organ, with very few exceptions. This fact holds true forboth
CPs. The tumour to normal surrounding muscle ratio has previ-
ously been found to range from 8:1 to 10:1 for CP(Me)3 and from
9:1 to 12:1 for CP(OMe)3, when including the autofluorescence in
the discrimination criterion (Nilsson et al, 1994).
Figures 3, 4, 7 and 8 show that the substance-related fluores-
cence was higher in the measurements of the empty bladders than
of the full ones, whereas the endogenous fluorescence was much
dominant in the case ofthe full bladders. Apossible explanation for
this is that when measuring on the empty bladders only the detrusor
muscle is probed, whereas in the case ofthe full bladders both the
urine and the muscular bladder wall are subjected to measurement.
Thus, this fact can be taken to point out the lack ofsignificant renal
excretion of, at least, the intact CPs. The above-mentioned figures
also indicate that the detrusor muscle appears to accumulate more
CP than plain skeletal muscle, as shown by the more intense (A)
fluorescence in the empty bladder than in thigh/leg muscle.
As has been mentioned earlier, a few additional peaks appeared
in some spectra and caused strong interference with the
carotenoporphyrin fluorescence peaks. In particular, these peaks
completely distorted some of the spectra from the gastrointestinal
system, the skin and the abdominal wall. The prominent peak at
672 nm, with a minor peak above 700 nm (Figure 2B), may be
attributed to degradation products ofchlorophyll a from the mouse
food pellets. The products mainly responsible for the fluorescence
are pheophorbide a and/or pheophytin a (Weagle et al, 1988). On
fluorescence analysis, the food pellets were confirmed to contain
large amounts of chlorophyll. Furthermore, the faeces were
analysed in a few animals, and were also found to exhibit a strong
fluorescence, consistent with a high chlorophyll degradation
product content. The less clearly understood peak at about 596 nm
(Figure 2C) might be attributed to bacterially synthesized
porphyrins (Harris and Werkhaver, 1987) or to a metalloporphyrin
(Moan, 1986, Plus, 1992). The small peak occasionally occurring
at approximately 630 nm (Figure 2D) is, most likely, due to
endogenous porphyrins.
In conclusion, CPs appear to be attractive tumour-localizing
substances forfluorescence diagnostics ofmalignant tumours. First
of all, the binding of a carotene moiety to a tetraphenylporphyrin
results in an efficient quenching of porphyrin triplet states, thus
hampering any unwanted photodynamic action of the porphyrin.
Moreover, the CPs display a tumourto normal fluorescence ratio as
high as 10 oreven betterforCP(OMe)3 (Reddi et al, 1994). In addi-
tion, all normal tissues analysed by LIF show a consistently lower
CP(Me)3 and CP(OMe)3 accumulation, as compared with tumour,
throughout the period 3-96 h past-injection interval. One notable
exception is the liver, which yields CP-fluorescence signals about
as intense as those observed for tumour exterior, with no apparent
decrease up to 96 h after i.v. administration of CP(Me)3. Previous
pharmacokinetic studies (Reddi et al, 1994) showed that the CP
content in liver is approximately constant for at least 8 weeks after
i.v. administration. Such a high accumulation and prolonged reten-
tion of CP in liver may represent a major limitation to the use of
CPs as photodiagnostic agents in vivo. We arepresently addressing
this problem by studying the pharmacokinetic properties of CPs
with different chemical structure and degree of hydro- and
lipophilicity, in order to enhance the clearance from liver and other
normal tissues without significantly reducing their affinity for
tumours.
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